JP2007524708A5 - - Google Patents

Download PDF

Info

Publication number
JP2007524708A5
JP2007524708A5 JP2007500287A JP2007500287A JP2007524708A5 JP 2007524708 A5 JP2007524708 A5 JP 2007524708A5 JP 2007500287 A JP2007500287 A JP 2007500287A JP 2007500287 A JP2007500287 A JP 2007500287A JP 2007524708 A5 JP2007524708 A5 JP 2007524708A5
Authority
JP
Japan
Prior art keywords
lactalbumin
bioactive
variant
complex
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007500287A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007524708A (ja
Filing date
Publication date
Priority claimed from GB0404339A external-priority patent/GB0404339D0/en
Priority claimed from GB0404358A external-priority patent/GB0404358D0/en
Priority claimed from GB0404369A external-priority patent/GB0404369D0/en
Application filed filed Critical
Priority claimed from PCT/GB2005/000685 external-priority patent/WO2005082406A1/en
Publication of JP2007524708A publication Critical patent/JP2007524708A/ja
Publication of JP2007524708A5 publication Critical patent/JP2007524708A5/ja
Pending legal-status Critical Current

Links

JP2007500287A 2004-02-26 2005-02-24 血管新生を阻害するラクトアルブミン Pending JP2007524708A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0404339A GB0404339D0 (en) 2004-02-26 2004-02-26 Therapeutic treatment
GB0404358A GB0404358D0 (en) 2004-02-26 2004-02-26 Therapeutic treatment
GB0404369A GB0404369D0 (en) 2004-02-26 2004-02-26 Novel therapies
PCT/GB2005/000685 WO2005082406A1 (en) 2004-02-26 2005-02-24 Lactalbumin for inhibiting angiogenesis

Publications (2)

Publication Number Publication Date
JP2007524708A JP2007524708A (ja) 2007-08-30
JP2007524708A5 true JP2007524708A5 (enExample) 2008-03-21

Family

ID=34915949

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007500287A Pending JP2007524708A (ja) 2004-02-26 2005-02-24 血管新生を阻害するラクトアルブミン

Country Status (4)

Country Link
US (1) US20080039381A1 (enExample)
EP (1) EP1727561A1 (enExample)
JP (1) JP2007524708A (enExample)
WO (1) WO2005082406A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210464D0 (en) * 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
WO2008138348A1 (en) * 2007-05-09 2008-11-20 Nya Hamlet Pharma Ab Preparation of complexed lactalbumin
US20100112702A1 (en) * 2008-02-25 2010-05-06 Klein Benjamin Y Method designed to divert glucose away from the glycolytic pathway
WO2009135494A2 (en) * 2008-05-09 2009-11-12 Nya Hamlet Pharma Ab Alpha-lactalbumin composition for the treatment of actinic keratosis
WO2010131237A1 (en) * 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
PL2882446T3 (pl) 2012-08-09 2018-10-31 Hamlet Pharma Ab Terapia profilaktyczna i nutraceutyczna
AU2023357946A1 (en) 2022-10-03 2025-04-24 Linnane Pharma Ab A complex comprising a alpha-lactalbumin and a fatty acid or lipid for use in the treatment or prevention of cancer
GB202303177D0 (en) 2023-03-03 2023-04-19 Linnane Pharma Ab Method of predicting response to treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2188903A (en) * 1938-12-03 1940-02-06 Dow Chemical Co Polystyrene compositions
GB9725126D0 (en) * 1997-11-27 1998-01-28 Svanborg Catharina Therapeutic agents
GB0205347D0 (en) * 2002-03-07 2002-04-24 Svanborg Catharina Biologically active complex
GB0210464D0 (en) * 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
GB0211658D0 (en) * 2002-05-22 2002-07-03 Svanborg Catharina Novel therapies and methods of screening for therapeutic compounds

Similar Documents

Publication Publication Date Title
Zhao et al. Molecular hydrogels of therapeutic agents
US20190023743A1 (en) Methods and compositions for modulating drug-polymer architecture, pharmacokinetics and biodistribution
US20080275120A1 (en) Leucine rich composition
WO2001027079A3 (en) Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease
CN101505746A (zh) 炎症的治疗方法
ES2215940T5 (es) Traccion proteica basica derivada de la leche como agente para reducir la hipertension.
JP2007524708A5 (enExample)
Ahmed et al. Therapeutic potential of marine peptides in glioblastoma: Mechanistic insights
EP4100041A1 (en) Treatment of panx1 associates diseases
Xiong et al. Fibrosis in fat: from other diseases to Crohn’s disease
US20210353757A1 (en) Nanobody preparation system for administration through internal and external epidermis of head and neck and preparation method and use
WO2000078327A3 (de) Mittel zur behandlung maligner erkrankungen unter verwendung von e1a-defizienten adenoviren mit yb-1 abhängiger replikation
JP5778692B2 (ja) 疾病抑制剤
JP2005530703A5 (enExample)
JP2006500321A5 (enExample)
CN103816534A (zh) 一种防治胃肠溃疡的纤连蛋白口服剂
JP2025505621A (ja) フェリチン重鎖１発現のアップレギュレーション
CA3058816A1 (en) Proteins derived from clpb and uses thereof
ES2968843T3 (es) Molécula de ARNm y agente fotosensibilizador para uso médico
NO20051159L (no) Preparater og fremgangsmater for behandling av sykdommer som viser feilsammensetting av aggregering av protein
EP4114843A1 (en) Method for producing a mammalian brain protein hydrolysate
RU2105567C1 (ru) Способ лечения злокачественных опухолей
JP2007533728A5 (enExample)
CN105477628B (zh) 抗癌组合物及其用途
JP2018520131A (ja) 新規ペプチド及びその用途